References
- Ulrich F, Heisenberg CP. Trafficking and cell migration. Traffic. 2009;10:811–818.
- Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev. 2005;15:87–96.
- Sahai E. Illuminating the metastatic process. Nat Rev Cancer. 2007;7:737–749.
- Ridley AJ. Rho GTPase signalling in cell migration. Curr Opin Cell Biol. 2015;36:103–112.
- Ding Q, Yoshimitsu M, Kuwahata T, et al. Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial–mesenchymal transition in pancreatic cancer. Hum Cell. 2012;25:1–8.
- Takahashi K, Fukushima K, Tanaka K, et al. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells. Exp Cell Res. 2018;369:316–324.
- Takahashi K, Fukushima K, Onish Y, et al. Involvement of FFA1 and FFA4 in the regulation of cellular functions during tumor progression in colon cancer cells. Exp Cell Res. 2018;369:54–60.
- Honoki K, Fujii H, Kubo A, et al. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance . Oncol Rep. 2010;24:501–505.
- Bauvois B. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta. 2012;1825:29–36.
- Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52–67.
- Tsujiuchi T, Araki M, Hirane M, et al. Lysophosphatidic acid receptors in cancer pathobiology. Histol Histopathol. 2014;29:313–321.
- Stoddard NC, Chun J. Promising pharmacological directions in the world of lysophosphatidic acid signaling. Biomol Ther. 2015;23:1–11.
- Aikawa S, Hashimoto T, Kano K, et al. Lysophosphatidic acid as a lipid mediator with multiple biological actions. J Biochem. 2015;157:81–89.
- Fells JI, Tsukahara R, Liu J, et al. Structure-based drug identifies novel LPA3 antagonists. Bioorg Med Chem. 2009;17:7457–7464.
- Hara T, Kashihara D, Ichimura A, et al. Role of free fatty acid receptors in the regulation of energy metabolism. Biochim Biophys Acta. 2014;1841:1292–1300.
- Hara T, Hirasawa A, Ichimura A, et al. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J Pharm Sci. 2011;100:3594–3601.
- Briscoe CP, Tadayyon M, Andrews JL, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem. 2003;278:11303–11311.
- Briscoe CP, Peat AJ, McKeown SC, et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol. 2006;148:619–628.